Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

18 août 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Receives Favorable Response From U.S. Food and Drug Administration Regarding Pediatric Study Plan for EVK-001

SOLANA BEACH, Calif., Aug. 18, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
13 août 2015 16h05 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Second Quarter 2015 Results

Enrolled 130 total subjects in Phase 3 clinical trial through end of July Recent FDA draft guidance of advice on Gastroparesis mirrors Evoke's Phase 3 clinical trial protocol design SOLANA...
30 juil. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2015 Financial Results

SOLANA BEACH, Calif., July 30, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
01 juil. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma to Present at Cantor Fitzgerald Inaugural Healthcare Conference

SOLANA BEACH, Calif., July 1, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, will host an...
24 juin 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Announces Publication of Clinical Data Demonstrating EVK-001 Significantly Improves Symptoms in Women With Diabetic Gastroparesis

SOLANA BEACH, Calif., June 24, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
14 mai 2015 16h05 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Reports First Quarter 2015 Results

SOLANA BEACH, Calif., May 14, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
30 avr. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Schedules Webcast and Conference Call for First Quarter 2015 Financial Results

SOLANA BEACH, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
14 avr. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Achieves Significant Manufacturing Milestone With Successful Completion of Commercial Scale Production of EVK-001

SOLANA BEACH, Calif., April 14, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
09 avr. 2015 08h30 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Granted European Union Formulation Patent for EVK-001

SOLANA BEACH, Calif., April 9, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
04 mars 2015 16h05 HE | Source: Evoke Pharma, Inc.

Evoke Pharma Reports Fourth Quarter and Year End 2014 Results

SOLANA BEACH, Calif., March 4, 2015 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...

Page précédente